Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.01.547355Source: DataRank Database

A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (27)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (27)

Kayode K. Ojo ORCID,Cynthia C.T. Sprenger ORCID,Kathryn S. Epilepsia ORCID,B. Gayani K. Perera ORCID,Mamatha Damodarasamy ORCID

Live enrichment

PubMed:37461469 OpenAlex:https://openalex.org/W4382934920

National Institutes of Health

Grant: 5P50CA097186-13

Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment

National Institutes of Health

Grant: 1R21CA255830-01

Identifying primary targets of bumped kinase inhibitor derived compounds to improve utility as therapy for castration resistant prostate cancer

green

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/07/03/2023.07.01.547355.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.07.01.547355

repositoryhttps://doi.org/10.1101/2023.07.01.547355

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37461469

Fields of Study

Cancer, Hypoxia, and MetabolismProstate Cancer Treatment and ResearchCancer Research and Treatments03 medical and health sciences0302 clinical medicine

Keywords

Prostate cancerCancerMedicineCancer researchIn vivoPharmacologyProstateEnzalutamideCancer cellPharmacokineticsInternal medicineBiologyMaleMiceCell Line, TumorHumansAnimalsProstatic NeoplasmsAntineoplastic AgentsGlycolysisXenograft Model Antitumor AssaysCell Proliferation

Sustainable Development Goals

SDG 0: Good health and well-being